Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Array BioPharma
Array BioPharma
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Array BioPharma closes cancer drug deal with Pierre Fabre
Array may receive up to US$425m in agreement to develop novel oncology products
Manufacturing
Accuratus expands capabilities with acquisition of CMC operations of Array Biopharma
The Array CMC operation will be known as Avista Pharma Solutions and housed in a state-of-the-art, laboratory facility in Longmont, Colorado
Regulatory
Anticancer agent – binimetinib
The new generation of genetically targeted anticancer agents is being developed for melanoma patients with specific mutations
Pharmaceutical
Array BioPharma appoints Victor Sandor as Chief Medical Officer
Clinical oncology expert joins as the company advances its late-stage clinical programmes
Pharmaceutical
Andrew Robbins joins Array BioPharma
Takes newly created role of senior vice president of commercial operations
Pharmaceutical
Array BioPharma appoints new ceo
Ron Squarer joins the US biopharmaceutical firm
Pharmaceutical
Array BioPharma names vp of Regulatory Affairs and Quality Assurance
Howard Holden brings 25 years’ experience to the role
Subscribe now